NewsCoronavirus

Actions

Study: Children experience higher omicron immunity after receiving Pfizer booster

COVID: Pfizer study on vaccines boosters for 5-11 year olds
COVID-19 Outbreak Kids Vaccine
Posted
and last updated

Pfizer announced Thursday that a third shot of its COVID-19 vaccine raised omicron-fighting antibody by 36 times in children ages 5 to 11.

Pfizer/BioNTech plans to request emergency use authorization from the FDA for a booster vaccine for this age group in the coming days.

The study looked at 140 children between 5 and 11 years old.

The children were administered a 10-microgram dose of the booster shot six months after their second dose.

That’s a smaller dose than what is administered to adults, which is 30 micrograms.

Omicron-fighting antibodies increased 36-fold from the levels recorded after the second dose of the Pfizer vaccine.

Antibodies levels against the original coronavirus strain increased 6-fold with the booster shot.

Scientists outside of Pfizer/BioNTech have not yet reviewed the new data.

The CDC has said that the spread of the omicron variant has led to a record number of COVID-19 cases in children, compared to other variants.

However, fewer than one-third of children in this age group have received two full of a COVID vaccine, according to CDC data.

,

Weather

Daily Forecast

View Hourly Forecast

Day

Conditions

HI / LO

Precip

Tuesday

07/01/2025

Clear

-° / 73°

0%

Wednesday

07/02/2025

Clear

103° / 73°

0%

Thursday

07/03/2025

Clear

102° / 69°

0%

Friday

07/04/2025

Clear

95° / 66°

0%

Saturday

07/05/2025

Clear

95° / 68°

0%

Sunday

07/06/2025

Clear

99° / 70°

0%

Monday

07/07/2025

Clear

101° / 71°

0%

Tuesday

07/08/2025

Clear

102° / 72°

0%